Pulmonary hypertension (PH) is a relatively common complication of left-heart disease and represents a challenging clinical situation for providers and patients alike. The aging demographic in the United States and widespread use of echocardiography in these patients often results in a consult to evaluate the PH. Unfortunately, proven treatment options are limited. Regardless, there is a critical need for PH experts to have a thorough understanding of the pathophysiology, clinical presentations and most appropriate management recommendations. The current issue offers the opportunity to review all of those issues in detail.

—Charles D. Burger, MD, Editor-in-Chief

Advances in Pulmonary Hypertension, Vol. 14, No. 2

Pulmonary Hypertension and Left Heart Disease